Table 1.

Patient Characteristics

	Compliant-to-treatment sample
	All (n=70)	Zileuton (n=52)	Zileuton + Celecoxib (n=18)	p-value
Age
Mean ± s.d.	43.6 ± 9.1	43.8 ± 9.6	43.1 ± 7.6	0.76
Gender				0.58
Female	27 (39%)	19 (37%)	8 (44%)
Male	43 (61%)	33 (63%)	10 (56%)
Race, n (%)				0.07
Asian	2 (3%)	0 (0%)	2 (11%)
Black	35 (50%)	28 (54%)	7 (39%)
White	33 (47%)	24 (46%)	9 (50%)
Smoking (Pack Year)
Median (range)	19.5 (10, 68)	19.5 (10, 68)	19.5 (10, 40)	0.59
Baseline PGE-M (ng/mg Cr)
Median (range)	12.6 (1.4, 50.4)	12.8 (1.4, 50.4)	10.2 (2.3, 35.1)	0.61
Baseline LTE4 (pg/mg Cr)
Median (range)	102.5 (4, 268)	107 (4, 268)	86.5 (37, 250)	0.42